Indeed, BRCA1 and FANCA (a member of the Fanconi Anemia family of proteins) are involved in detecting DNA damage, causing cell cycle arrest and allowing DNA repair, which contributes to chemoresistance [24], while disruption of the BRCA1 pathway may promote sensitivity to platinum-based therapies [25,26]. Here, FANCA is linked to anemia (phenotype).